Nautilus Group Inc (The) Stock News

Health and wellness continue to be a focus for Americans. Here are seven stocks to buy from the Global X Health & Wellness ETF.

Nautilus is a smaller player in the connected fitness industry which is undergoing a business transformation. The company seems to be currently undervalued assuming continuity of the business.

Nautilus: Home Fitness Isn't Going Away, NLS Stock Is Absurdly Cheap

VANCOUVER, Wash.--(BUSINESS WIRE)--Nautilus, Inc. (NYSE: NLS) (“Nautilus,” “the Company”), a global leader in digitally connected home fitness solutions, today announced that it has granted eq

Wall Street often overlooks penny stocks. Retail investors can use a winning strategy to get ahead of the curve and beat out hedge funds.

VANCOUVER, Wash.--(BUSINESS WIRE)--Nautilus, Inc. (the “Company”) (NYSE: NLS) today announced that Jim Barr, the Company's Chief Executive Officer, and Aina Konold, the Company's Chief Financial O

As the delta variant drives a rapid increase in Covid-19 cases, consider these stocks to buy for another potential round of restrictions. The post 7 Coronavirus Stocks to Buy in Case of Lockdown 2.0 a

NLS Pharmaceutics Ltd (NASDAQ: NLSP) has received a Notice of Allowance from the U.S. Patent and Trademark Office for patent application No. 16/083,131.

The market seems to be pricing the worst-case scenario for Nautilus.

Growth is decelerating, and the market doesn't like it.

Nautilus (NLS) delivered earnings and revenue surprises of 43.33% and 8.76%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Shares of Nautilus (NYSE:NLS) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 54.26% over the past year to $0.43, which beat the est

VANCOUVER, Wash.--(BUSINESS WIRE)--Nautilus, Inc. (NYSE: NLS), an innovation leader in connected home fitness, today announced a licensing agreement with leading digital fitness provider FitOn to furt

Nautilus Biotechnology Inc (NASDAQ: NAUT) shares are trading higher during mid-day trading on Thursday following a CNBC report that Amazon.com Inc (NASDAQ: AMZN) held around $15 million stake in

Shares of Nautilus Biotechnology rose by as much as 50% on Thursday morning after a report revealed that Amazon has taken an equity stake in the newly public Seattle-based company.